About 800 reports

Oncology Drugs In Pipeline

  • Oncology
  • World
  • APAC
  • Health Expenditure
  • Drug Approval

## MEDICAL ONCOLOGY

  • Healthcare
  • Patient Data Management
  • Oncology
  • Oncology
  • World
  • United States
  • North America
  • APAC
  • Medical Technology Density
  • Health Expenditure

Figure ##. Generic Oncology Drugs Market Segmentation

  • Oncology
  • World
  • APAC
  • United States
  • Cancer Incidence
  • Mortality Rate

Oncology Devices Global Market Report 2020-30: Covid 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global oncology devices market. This report focuses on oncology devices market which is experiencing strong growth. The report gives a guide to the...

  • Marketing Research
  • Hormone
  • Infectious Disease
  • Immunotherapy
  • Biopharmaceutical
  • Chemotherapy
  • World

This study explores the global immuno-oncology (I-O) market’s evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune system is the...

  • Infectious Disease
  • Targeted Therapy
  • Cancer Immunotherapy
  • Pharmaceutical
  • Gene Therapy
  • Monoclonal Antibody
  • Cell Therapy
  • World

## HEMATO-ONCOLOGY TESTING MARKET, BY REGION

  • Oncology
  • United States
  • Europe
  • APAC
  • Canada
  • North America
  • Drug Approval
  • Health Expenditure Per Capita

Major players in the immuno-oncology drugs market are Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, and AbbVie Inc. The global immuno-oncology drugs market is expected to decline from $59.64 billion in...

  • Oncology
  • World
  • Cancer Incidence
  • Cancer Mortality

INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION

  • Oncology
  • Oncology
  • APAC
  • Latin America
  • Cancer Incidence
  • Drug Approval

## IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT

  • Oncology
  • North America
  • APAC
  • Cancer Incidence
  • Mortality Rate

The Global Veterinary oncology Market size is expected to reach $369.2 Million by 2026, rising at a market growth of 13.2% CAGR during the forecast period. Cancer is one of the main causes of morbidity in veterinary patients and one of the most important surgical procedures undertaken by veterinarians is the surgical removal of tumors. The...

  • Therapy
  • Oncology
  • Cancer
  • World
  • Asia
  • North America
  • APAC

U.S. Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, And Segment Forecasts, 2020 - 2027 The U.S. Radiation Oncology Market Growth & Trends The U.S. radiation oncology...

  • Healthcare
  • Specialty Hospital
  • Clinical Trial
  • Health Care Provider
  • Cancer
  • Oncology
  • United States

Global Oncology Drugs Market, By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent), By Route of Administration (Oral, Intravenous, Subcutaneous, Others), By Gender (Male, Female), By...

  • Oncology
  • World
  • Health Expenditure

Immuno-oncology is a unique approach that uses the body’s immune system to fight cancer. These therapies activate an individual’s immune system, making it able to recognize cancer cells and destroy them. Immuno-oncology therapies provide long lasting anti-cancer benefits to patients who previously had very few treatment...

  • Oncology
  • World

China Oncology Drugs Market by Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy) and Indication (Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Skin Cancer, Ovarian Cancer, Cervical Cancer, Kidney Cancer, and Other Cancers): Opportunity Analysis and Industry Forecast,...

  • Cancer
  • Oncology
  • China
  • World
  • Cancer Mortality
  • Cancer Incidence

Oncology/Cancer Drugs Market by Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy) and Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Others): Global Opportunity Analysis...

  • Oncology
  • World
  • APAC

Kinase-targeted cancer therapies became really big with imatinib (Gleevec), a landmark drug that has vastly improved the outcomes of patients with chronic myelogenous leukemia. With the human genome encoding 538 protein kinases and many of these kinases being associated with human cancer initiation and progression, this field carries a lot...

  • Targeted Therapy
  • World
  • Drug Approval

BNOAT Oncology Inc

  • Cancer
  • Therapy
  • Drug Development
  • Oncology
  • Oncology
  • Biopharmaceutical
  • World
  • Pharmaceutical Registrations
  • Drug Approval

Gibson Oncology LLC

  • Oncology
  • World
  • Industrial Production

Taiho Oncology Inc

  • Therapy
  • Cancer
  • Oncology
  • Oncology
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations
  • Drug Approval

Synthetic Peptide for Oncology – Drug Profile

  • Cancer
  • Pharmaceutical
  • Therapy
  • Drug Development
  • Oncology
  • Colorectal Cancer
  • World
  • Biologics Production
  • Manufacturing Output

Polysaccharides to Inhibit Heparanase for Oncology – Drug Profile

  • Therapy
  • Drug Development
  • Oncology
  • Type 2 Diabetes
  • World

Sierra Oncology Inc

  • Oncology
  • Drug Development
  • Therapy
  • Pancreatic Cancer
  • Pharmaceutical
  • World
  • Pharmaceutical Exports

Cellular Immunotherapy for Oncology – Drug Profile

  • Cancer
  • Therapy
  • Oncology
  • Pharmaceutical
  • Drug Development
  • Cell Therapy
  • Biotechnology
  • World
  • Pharmaceutical Registrations
  • Drug Approval

Global DNA Damage Response Drugs Market to Reach $24,848.8 Million by 2030 Market Report Coverage - DNA Damage Response Drugs Market Segmentation • Commercialized Drugs – Lynparza, Talzenna, Zejula, and Rubraca • Pipeline Analysis (by Mechanism of Action)- PARP Inhibitor, WEE1 Kinase Inhibitor,...

  • Oncology
  • Therapy
  • Targeted Therapy
  • World
  • APAC
  • Cancer Survival Rate

Cellular Immunotherapy for Oncology – Drug Profile

  • Therapy
  • Chemotherapy
  • Cell Therapy
  • Drug Development
  • Oncology
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations
  • Drug Approval

Small Molecules to Inhibit TDO for Oncology – Drug Profile

  • Oncology
  • Pharmaceutical
  • Renal Disease
  • Research Center
  • World
  • Jiangsu
  • Netherlands

Small Molecules to Inhibit CD## for Oncology - Drug Profile

  • Oncology
  • Monoclonal Antibody
  • Ovarian Cancer
  • Pharmaceutical
  • World

Small Molecules to Inhibit TDO for Oncology – Drug Profile

  • Oncology
  • Pharmaceutical
  • Research Center
  • World
  • Netherlands
  • Jiangsu

Small Molecule to Inhibit RAF## for Oncology – Drug Profile

  • Oncology
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations

Gibson Oncology LLC

  • Cancer
  • Oncology
  • World
  • Industrial Production